Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

O. Garrone · SciRah

Researcher profile · Semantic Scholar

O. Garrone

Share profile

O. Garrone — researcher profile on SciRah

h-index: 38
Works: 359
Citations: 7,197

Most-cited papers

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
J. van de Haar, Xu-Hui Ma, S. Ooft, Pim W. van der Helm +46 more
2023Nature Medicine80 citations Open access
Semantic Scholar
CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety.
D. Wekking, M. Lambertini, M. Dessì, N. Denaro +4 more
2024Seminars in Oncology44 citations Open access
Semantic Scholar
Physical activity and exercise health benefits: cancer prevention, interception, and survival
Adriana Albini, C. la Vecchia, F. Magnoni, O. Garrone +6 more
2024European Journal of Cancer Prevention40 citations
Semantic Scholar
Postbiotics as Adjuvant Therapy in Cancer Care
Vyshnavy Balendra, Roberto Rosenfeld, Chiara Amoroso, Cecilia Castagnone +3 more
2024Nutrients37 citations Open access
Semantic Scholar
Basosquamous Carcinoma: Comprehensive Clinical and Histopathological Aspects, Novel Imaging Tools, and Therapeutic Approaches
Giulia Murgia, N. Denaro, F. Boggio, G. Nazzaro +5 more
2023Cells31 citations Open access
Semantic Scholar
Quantitative and Qualitative Radiological Assessment of Sarcopenia and Cachexia in Cancer Patients: A Systematic Review
Sveva Mortellaro, Sonia Triggiani, Federica Mascaretti, Micol Galloni +3 more
2024Journal of Personalized Medicine20 citations Open access
Semantic Scholar
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan
A. Fabi, Alessandro Rossi, R. Caputo, S. Pisegna +20 more
2025npj Precision Oncology15 citations Open access
Semantic Scholar
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer
M. Dieci, G. Bisagni, S. Bartolini, A. Schirone +18 more
2025JAMA Oncology15 citations Open access
Semantic Scholar
Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis
F. Petrelli, A. Parisi, G. Tomasello, E. Mini +6 more
2023BMC Gastroenterology14 citations Open access
Semantic Scholar
Artificial Intelligence for Precision Oncology of Triple-Negative Breast Cancer: Learning from Melanoma
O. Garrone, C. L. La Porta
2024Cancers13 citations Open access
Semantic Scholar
Multidisciplinary management of immunotherapy‐related adverse events in solid tumors: An inter‐institutional and telemedicine‐based working team
A. Iaculli, M. Ghidini, F. Locati, L. Chiappa +5 more
2024Cancer Medicine13 citations Open access
Semantic Scholar
Prognostic Value of HER2-low Status in ER+ Early Breast Cancer: A Systematic Review and Meta-Analysis
F. Petrelli, C. Rea, M. Parati, K. Borgonovo +7 more
2023Anticancer Research13 citations Open access
Semantic Scholar
Moderate physical activity during neoadjuvant chemotherapy in breast cancer patients: effect on cancer-related inflammation and pathological complete response—the Neo-Runner study
O. Garrone, M. Paccagnella, A. Abbona, F. Ruatta +11 more
2024ESMO Open10 citations Open access
Semantic Scholar
Circulating tumor DNA dynamics and clinical outcome in metastatic colorectal cancer patients undergoing front-line chemotherapy.
M. Ghidini, J. Hahne, C. Senti, Timon Heide +24 more
2024Clinical Cancer Research10 citations
Semantic Scholar
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study
F. S. Di Lisa, E. Krasniqi, L. Pizzuti, M. Barba +80 more
2023Frontiers in Oncology10 citations Open access
Semantic Scholar
Thyroid findings in pediatric and adult patients with PTEN hamartoma tumor syndrome: A retrospective analysis, and literature review
D. Milani, Alessia Dolci, I. Muller, M. Pavesi +10 more
2023Endocrine10 citations
Semantic Scholar
Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study
S. Scagnoli, S. Pisegna, A. Toss, R. Caputo +28 more
2024npj Breast Cancer9 citations Open access
Semantic Scholar
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience
M. Salati, M. Ghidini, M. Paccagnella, Luca Reggiani Bonetti +9 more
2023International Journal of Molecular Sciences9 citations Open access
Semantic Scholar
Cemiplimab in Ultra-Octogenarian Patients with Cutaneous Squamous Cell Carcinoma: The Real-Life Experience of a Tertiary Referral Center
N. Denaro, E. Passoni, A. Indini, G. Nazzaro +8 more
2023Vaccines7 citations Open access
Semantic Scholar
Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis
M. Ghidini, F. Petrelli, M. Paccagnella, M. Salati +14 more
2025Cancers6 citations Open access
Semantic Scholar
Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials
F. Petrelli, G. Tomasello, M. Parati, A. Ghidini +9 more
2024Medicina6 citations Open access
Semantic Scholar
Management and Future Therapeutic Perspectives of Classic Kaposi’s Sarcoma: An Evidence-Based Review
N. Denaro, A. Indini, Lucia Brambilla, A. Marzano +2 more
2024OncoTargets and Therapy6 citations Open access
Semantic Scholar
Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysis.
F. Petrelli, A. Ghidini, C. Rea, M. Parati +7 more
2024Current Problems in Cancer6 citations
Semantic Scholar
Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial
F. Poggio, E. Blondeaux, M. Tagliamento, M. Perachino +26 more
2024ESMO Open6 citations
Semantic Scholar
The oligometastatic setting in HNSCC: A critical review by the Rete Oncologica Piemonte e Valle d'Aosta multidisciplinary team.
N. Denaro, G. Succo, O. Ostellino, M. Airoldi +5 more
2023Critical reviews in oncology/hematology6 citations
Semantic Scholar
Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic review
Roberto Rosenfeld, S. Sganga, M. Badalamenti, Sveva Mortellaro +6 more
2025Journal of Cancer Research and Clinical Oncology5 citations Open access
Semantic Scholar
Castleman Disease and Kaposi Sarcoma: A Review of the Literature and a Case Series
N. Denaro, Lucia Brambilla, Federica Scarfì, A. Tourlaki +5 more
2025Journal of Clinical Medicine5 citations Open access
Semantic Scholar
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors
R. Scafetta, M. Donato, C. Gullotta, A. Guarino +66 more
2025Breast5 citations Open access
Semantic Scholar
Nutrition in HNSCC: is it a matter for oncologists? The role of multidisciplinary team—a narrative literature review
N. Denaro, C. Bareggi, B. Galassi, G. Beltramini +5 more
2024Frontiers in Oncology5 citations Open access
Semantic Scholar
Sarcoidosis-Like Reaction in Melanoma Patients Receiving Immunotherapy or Targeted Therapy
Giulia Murgia, L. Valtellini, G. Nazzaro, E. Passoni +5 more
2024Case Reports in Oncological Medicine5 citations Open access
Semantic Scholar
Impact of ketogenic and fast-mimicking diet in gastrointestinal cancer treatment
E. Colombo, M. Righini, Vyshnavy Balendra, Konul Rustamli +3 more
2025Frontiers in Oncology4 citations Open access
Semantic Scholar
Current Evidence in the Systemic Treatment of Brain Metastases from Breast Cancer and Future Perspectives on New Drugs, Combinations and Administration Routes: A Narrative Review
O. Garrone, F. Ruatta, C. Rea, N. Denaro +6 more
2024Cancers4 citations
Semantic Scholar
Effects of a Personalized Diet on Nutritional Status and Renal Function Outcome in Nephrectomized Patients with Renal Cancer
F. Trevisani, Fabiana Laurenti, F. Fiorio, M. Paccagnella +8 more
2024Nutrients4 citations Open access
Semantic Scholar
Therapeutic vaccines targeting HPV epitopes in human papillomavirus – positive oropharyngeal cancer: a critical review
Giovanna Rossi, F. Tartaglia, N. Denaro, M. Ghidini +7 more
2026Frontiers in Immunology3 citations Open access
Semantic Scholar
Therapy-Induced Metastatic Melanoma During Treatment With Encorafenib and Cetuximab for BRAF-Mutated Colorectal Cancer: A Case Report and Short Literature Review.
N. Denaro, R. Marsicano, B. Galassi, Sveva Mortellaro +4 more
2025Clinical colorectal cancer3 citations
Semantic Scholar
Immunotherapy-Associated Renal Dysfunction in Metastatic Cancer: An Emerging Challenge in Onco-Nephrology
F. Trevisani, Andrea Angioi, M. Ghidini, M. Floris +5 more
2025Cancers3 citations Open access
Semantic Scholar
First line therapy in stage IV BRAF mutated colorectal cancer
F. Petrelli, M. Antista, L. Dottorini, A. Russo +8 more
2024Heliyon3 citations
Semantic Scholar
A Prospective Monocentric Study of Invasive Breast Carcinoma Diagnosed at 80 Years and Older: Survival Outcomes and Peculiar Challenges
D. Gambini, Valentina Veronesi, L. Despini, S. Ferrero +6 more
2024Cancers3 citations Open access
Semantic Scholar
Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib
A. Abbona, V. Ricci, M. Paccagnella, C. Granetto +7 more
2023Vaccines3 citations Open access
Semantic Scholar
Prognostic Significance of MSI and EBV Positivity in PD‐L1 Positive Gastric Cancer: A Systematic Review and Meta‐Analysis
F. Petrelli, M. Antista, A. Ghidini, V. Rampulla +8 more
2026Cancer Medicine2 citations Open access
Semantic Scholar
Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER study
L. Pontolillo, E. Munzone, P. Vigneri, M. Pistelli +25 more
2026Breast2 citations Open access
Semantic Scholar
Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study
M. Cazzaniga, V. Cogliati, E. Rossi, I. Paris +19 more
2026ESMO real world data and digital oncology2 citations Open access
Semantic Scholar
Effect of aspirin use on cancer incidence and mortality: An updated systematic review and meta-analysis.
F. Petrelli, A. Ghidini, M. Antista, Nicole Meli +7 more
2025Public Health2 citations
Semantic Scholar
239MO TILs and overall survival (OS) in HER2+ early breast cancer (eBC): 10-year (yr) updated analysis of the ShortHER trial
M. Dieci, G. Bisagni, S. Bartolini, A. Schirone +16 more
2024Annals of Oncology2 citations Open access
Semantic Scholar
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study
M. Cazzaniga, P. Pronzato, D. Amoroso, A. Bernardo +38 more
2023Cancers2 citations Open access
Semantic Scholar
A narrative review of the principal glucocorticoids employed in cancer.
N. Denaro, O. Garrone, A. Morelli, Benedetta Pellegrino +8 more
2023Seminars in Oncology2 citations
Semantic Scholar
Broad baseline-variable profiling of visceral conversion in bone-only HR+/HER2 - metastatic breast cancer treated with CDK4/6 inhibitors.
R. Scafetta, R. Troiano, A. Guarino, C. Gullotta +79 more
2026European Journal of Cancer1 citations Open access
Semantic Scholar
The role of a multidisciplinary approach in non-melanoma skin cancer management.
Francesca Lussana, N. Denaro, E. Passoni, Giulia Murgia +10 more
2026Dermatology Reports1 citations Open access
Semantic Scholar
Abstract PS4-12-24: Risk and Pattern of Relapse in Triple-Negative Breast Cancer with Pathological Complete Response after Neoadjuvant Treatment: Updated Results from the European GAMBIT Real-world Study
M. Dieci, T. Foukakis, S. Giacchetti, C. Desmedt +35 more
2026Clinical Cancer Research1 citations
Semantic Scholar
Abstract PS2-08-11: Artificial Intelligence (AI)-based spatial assessment of tumor-infiltrating lymphocytes (TIL) and outcome in early HER2+ breast cancer (BC): ancillary study of the phase III adjuvant ShortHER trial
M. Dieci, K. AbdulJabbar, G. Bisagni, S. Bartolini +18 more
2026Clinical Cancer Research1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Ghidini×22
Invite
M. Ghidini — researcher profile on SciRah
N. Denaro×16
Invite
N. Denaro — researcher profile on SciRah
G. Tomasello×12
Invite
G. Tomasello — researcher profile on SciRah
C. Solinas×7
Invite
C. Solinas — researcher profile on SciRah

×6

Invite

F. Petrelli — researcher profile on SciRah

Invite

E. Passoni — researcher profile on SciRah

Invite

S. Scagnoli — researcher profile on SciRah

Invite

I. Paris — researcher profile on SciRah

A. Botticelli×5

Invite

A. Botticelli — researcher profile on SciRah

Invite

F. Ruatta — researcher profile on SciRah

U. de Giorgi×5

Invite

U. de Giorgi — researcher profile on SciRah

Invite

B. Galassi — researcher profile on SciRah